World News | Indonesia Expects Halal Certificate for Experimental Vaccine
Get latest articles and stories on World at LatestLY. Indonesia's highest Muslim clerical body is expected to issue a halal certification for the experimental COVID-19 vaccine developed by China-based Sinovac Biotech, officials said on Monday.
Jakarta, Dec 7 (AP) Indonesia's highest Muslim clerical body is expected to issue a halal certification for the experimental COVID-19 vaccine developed by China-based Sinovac Biotech, officials said on Monday.
The certification would be a significant step in immunization efforts in the world's most populous Muslim country, should the vaccine be approved for use.
Also Read | Shaheen IX: China-Pakistan Air Forces to Hold Joint Exercises in Bholari at Thatta District.
"A study by the Indonesian Ulema Council Halal Product Guarantee Agency and Institute for the Assessment of Food, Drugs and Cosmetics has been completed and has been submitted to the council for the making of a fatwa and halal certification," Human Development and Culture Minister Muhadjir Effendy said at a news conference.
Over one million doses of the experimental COVID-19 vaccine developed by Sinovac arrived in Indonesia on Sunday evening. The government has no exact schedule for distributing the doses.
Health Minister Terawan Agus Putranto said on Monday that the experimental vaccine needs to successfully complete phase-three clinical trials before it can be distributed in Indonesia.
"The government will provide a vaccine that is proven safe and passes clinical trials under World Health Organization recommendations," Putranto said.
Hermawan Saputra of the Indonesian Public Health Expert Association said the 1.2 million doses are only enough for an initial group of 600,000 people, since each person must receive two doses.
"It does not really have significant meaning. The government should guarantee that there will be enough to for distribution to the entire country," Saputra said.
Saputra said that if the experimental vaccine passes the third-phase clinical trials, immunization programs are expected to begin in the middle of next year.
The government has announced that it plans to use vaccines from several different producers in its effort to vaccinate the world's fourth most populated country. So far, the Sinovac candidate vaccine is the only one to arrive in the country.
Monday, the Health Ministry announced 5,754 new COVID-19 cases, bringing the confirmed total to 581,550, including 17,867 deaths, the highest in Southeast Asia. (AP)
(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)